Allakos Inc.
ANTI-SIGLEC-7 ANTIBODIES HAVING REDUCED EFFECTOR FUNCTION
Last updated:
Abstract:
The invention provides methods and compositions for the treatment of cancer using anti-Siglec-7 antibodies that have reduced effector function.
Status:
Application
Type:
Utility
Filling date:
11 Jan 2019
Issue date:
25 Feb 2021